Legal Representation
Attorney
Ashley Hatzenbihler
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 15, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 15, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 15, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 15, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 15, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 6, 2021 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 5, 2021 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 1, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 6, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 6, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 16, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 3, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 3, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 3, 2020 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 3, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 3, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 31, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 29, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 27, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medical diagnostic rapid test kits primarily comprising of diagnostic test strips capable of visual or instrument read-out of test results and medical diagnostic reagents and developer solution for testing of bodily fluids and also including blood collection needles and vials, all for use in detecting antibodies, antigen, viruses, diseases, nucleic acids, pathogens and proteins; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; all the above for use in relation to COVID-19
Additional Information
Pseudo Mark
COVID-IG EXPRESS
Classification
International Classes
005